Finch Trades

As of market close
September 25, 2026
Update frequency: every Saturday morning
Transaction
Position
Overall
Group
Year
Company
An icon graphic of an arrow.
Ticker
An icon graphic of an arrow.
Entry Date
An icon graphic of an arrow.
Group
An icon graphic of an arrow.
Status
An icon graphic of an arrow.
Cost Basis
An icon graphic of an arrow.
Last Price
An icon graphic of an arrow.
Principal
An icon graphic of an arrow.
Last Value
An icon graphic of an arrow.
% Change
An icon graphic of an arrow.
vs. SPY
An icon graphic of an arrow.
Click individual row to view transaction details
BridgeBio Oncology Therapeutics
$BBOT
7/8/26
Future Compounder
Active
Exited
9986
$8.74
$3.95
$500
$226
-54.8%
-57.9%
Relay Therapeutics
$RLAY
5/19/26
Future Compounder
Active
Exited
9987
$12.31
$17.47
$950
$1,349
42.0%
37.2%
Relay Therapeutics
$RLAY
5/18/26
Future Compounder
Active
Exited
9988
$12.32
$17.47
$2,500
$3,545
41.8%
37.6%
Relay Therapeutics
$RLAY
5/5/26
Future Compounder
Active
Exited
9989
$12.95
$17.47
$2,500
$3,373
34.9%
28.6%
Relay Therapeutics
$RLAY
3/13/26
Future Compounder
Active
Exited
9990
$10.40
$17.47
$1,250
$2,100
68.0%
51.7%
Relay Therapeutics
$RLAY
3/12/26
Future Compounder
Active
Exited
9991
$10.40
$17.47
$1,250
$2,100
68.0%
52.6%
Coherus Oncology
$CHRS
3/6/26
Future Compounder
Active
Exited
9992
$1.75
$1.2160
$2,500
$1,737
-30.5%
-45.1%
Codexis
$CDXS
3/2/26
Future Compounder
Active
Exited
9993
$1.00
$1.32
$1,000
$1,320
32.0%
19.6%
Harmony Biosciences
$HRMY
2/20/26
Opportunistic
Active
Exited
9994
$30.75
$28.50
$1,750
$1,622
-7.3%
-7.4%
Harmony Biosciences
$HRMY
5/2/25
Current Compounder
Active
Exited
9995
$30.00
$28.50
$23,245
$22,083
-5.0%
-25.7%
Exact Sciences
$EXAS
4/30/25
Opportunistic
Active
Exited
9999
$44.69
$53.05
$10,000
$11,871
18.7%
14.9%
Blueprint Medicines
$BPMC
4/30/25
Opportunistic
Active
Exited
10000
$88.21
$98.73
$10,000
$11,193
11.9%
8.9%
Coherus Oncology
$CHRS
3/27/25
Future Compounder
Active
Exited
$0.86
$1.2200
$250
$355
42.0%
5.8%
Coherus Oncology
$CHRS
1/21/25
Future Compounder
Active
Exited
$1.37
$1.2200
$1,000
$891
-10.9%
-39.1%
Relay Therapeutics
$RLAY
1/10/25
Future Compounder
Active
Exited
$4.32
$17.47
$7,000
$28,321
304.6%
271.7%
AVITA Medical
$RCEL
1/8/25
Future Compounder
Active
Exited
9998
$9.53
$7.45
$1,000
$782
-21.8%
-18.5%
Relay Therapeutics
$RLAY
12/10/24
Future Compounder
Active
Exited
$4.44
$17.47
$2,500
$9,826
293.0%
265.1%
Relay Therapeutics
$RLAY
12/3/24
Future Compounder
Active
Exited
$4.45
$17.47
$2,500
$9,826
293.0%
265.3%
Relay Therapeutics
$RLAY
11/20/24
Future Compounder
Active
Exited
$4.55
$17.47
$2,000
$7,681
284.0%
253.4%
Relay Therapeutics
$RLAY
10/29/24
Future Compounder
Active
Exited
$5.80
$17.47
$1,000
$3,015
201.5%
168.9%
Arrowhead Pharma
$ARWR
10/1/24
Future Compounder
Active
Exited
9996
$18.48
$63.64
$1,000
$3,444
244.4%
224.2%
Relay Therapeutics
$RLAY
9/25/24
Future Compounder
Active
Exited
$7.00
$17.47
$725
$1,809
149.6%
114.3%
Arrowhead Pharma
$ARWR
9/25/24
Future Compounder
Active
Exited
9997
$19.48
$63.64
$1,000
$3,268
226.8%
206.9%
Relay Therapeutics
$RLAY
9/13/24
Future Compounder
Active
Exited
$7.55
$17.47
$1,000
$2,314
131.4%
94.1%
Relay Therapeutics
$RLAY
9/5/24
Future Compounder
Active
Exited
$6.18
$17.47
$2,000
$5,654
182.7%
142.3%
Coherus Oncology
$CHRS
7/2/24
Future Compounder
Active
Exited
$1.40
$1.2200
$1,000
$875
-12.5%
-53.3%
Exact Sciences
$EXAS
5/29/24
Current Compounder
Active
Exited
$44.98
$105.00
$1,000
$2,334
133.4%
108.8%
Relay Therapeutics
$RLAY
5/29/24
Future Compounder
Active
Exited
$6.28
$17.47
$1,000
$2,784
178.4%
131.8%
Coherus Oncology
$CHRS
4/25/24
Future Compounder
Active
Exited
$1.93
$1.2109
$6,996
$4,390
-37.3%
-90.7%
Position
An icon graphic of an arrow.
Ticker
An icon graphic of an arrow.
Group
An icon graphic of an arrow.
Status
An icon graphic of an arrow.
Shares
An icon graphic of an arrow.
Cost Basis
An icon graphic of an arrow.
Last Price
An icon graphic of an arrow.
Principal
An icon graphic of an arrow.
Last Value
An icon graphic of an arrow.
% Change
An icon graphic of an arrow.
vs. SPY
An icon graphic of an arrow.
Click individual row to view position details
Cash
Cash
$27,579
Relay Therapeutics
$RLAY
Future Compounder
Building
Building
Building
1
4,790.8
$5.88
$17.47
$28,175
$83,695
197.1%
171.4%
Codexis
$CDXS
Future Compounder
Building
Building
Building
2
1,000.0
$1.00
$1.32
$1,000
$1,320
32.0%
19.6%
BridgeBio Oncology Therapeutics
$BBOT
Future Compounder
Full
Full
Full
4
57.2
$8.74
$3.95
$500
$226
-54.8%
-57.9%
Coherus Oncology
$CHRS
Future Compounder
Exited
Exited
Exited
993
6,791.3
$1.73
$1.21
$11,746
$8,247
-29.8%
-71.4%
Harmony Biosciences
$HRMY
Opportunistic
Exited
Exited
Exited
994
56.9
$30.75
$28.50
$1,750
$1,622
-7.3%
-7.4%
Harmony Biosciences
$HRMY
Current Compounder
Exited
Exited
Exited
995
774.8
$30.00
$28.50
$23,245
$22,083
-5.0%
-25.7%
Exact Sciences
$EXAS
Current Compounder
Exited
Exited
Exited
996
22.2
$44.98
$105.00
$1,000
$2,334
133.4%
108.8%
Arrowhead Pharma
$ARWR
Future Compounder
Exited
Exited
Exited
997
105.5
$18.96
$63.64
$2,000
$6,712
235.6%
206.9%
AVITA Medical
$RCEL
Future Compounder
Exited
Exited
Exited
998
104.9
$9.53
$7.45
$1,000
$782
-21.8%
-18.3%
Exact Sciences
$EXAS
Opportunistic
Exited
Exited
Exited
999
223.8
$44.69
$53.05
$10,000
$11,871
18.7%
14.9%
Blueprint Medicines
$BPMC
Opportunistic
Exited
Exited
Exited
1000
113.4
$88.21
$98.73
$10,000
$11,193
11.9%
8.9%

$53,153

Principal

$112,820

Current Value

112.3%

Total Return
(from April 2024)

36.5%

CAGR
(from April 2024)
Benchmark
An icon graphic of an arrow.
Ticker
An icon graphic of an arrow.
Principal
An icon graphic of an arrow.
Current Value
An icon graphic of an arrow.
$ Change
An icon graphic of an arrow.
% Change
An icon graphic of an arrow.
Finch Trades vs.
An icon graphic of an arrow.
Finch Trades
$FINCH
$53,153
$112,820
$59,667
112.3%
0.0%
If S&P 500
$SPY
$53,153
$69,799
$16,646
31.3%
80.9%
If XBI
$XBI
$53,153
$89,305
$36,152
68.0%
44.2%
If Nasdaq 100
$QQQ
$53,153
$77,949
$24,796
46.7%
65.6%
If ARKG
$ARKG
$53,153
$106,338
$53,185
100.1%
12.2%
Group
An icon graphic of an arrow.
Principal
An icon graphic of an arrow.
Last Value
An icon graphic of an arrow.
% Change
An icon graphic of an arrow.
vs. SPY
An icon graphic of an arrow.
vs. QQQ
An icon graphic of an arrow.
vs. XBI
An icon graphic of an arrow.
vs. ARKG
An icon graphic of an arrow.
Opportunistic
$21,750
$24,686
13.5%
10.3%
11.6%
13.3%
13.0%
Future Compounder
$44,421
$100,982
127.3%
98.9%
86.7%
72.5%
34.2%
Current Compounder
$24,245
$24,417
0.7%
-20.2%
-23.6%
-50.8%
-30.6%
* This view tracks performance by the portfolio allocation group without accounting for reinvested proceeds.
Year
An icon graphic of an arrow.
Principal
An icon graphic of an arrow.
Last Value
An icon graphic of an arrow.
% Change
An icon graphic of an arrow.
vs. SPY
An icon graphic of an arrow.
vs. QQQ
An icon graphic of an arrow.
vs. XBI
An icon graphic of an arrow.
vs. ARKG
An icon graphic of an arrow.
2024
$23,721
$57,218
141.2%
103.2%
87.1%
73.5%
46.5%
2025
$52,495
$75,494
43.8%
28.3%
25.3%
9.4%
12.3%
2026
$14,200
$17,371
22.3%
13.8%
9.7%
3.0%
-48.6%
* This view tracks performance by the year principal was invested without accounting for reinvested proceeds.
Research Notes
MOS Dashboard
ABOUT
What Is Solt DB?
Public Benefit
Our Lonely Team
PUBLIC CONTENT
Articles
Data Visualizations
Newsletter
INVESTING
Pricing
Member Benefits
CONTACT
Questions?
Critiques?
Love letters?

Reach out here.
About Solt DB

Solt DB is an equities research firm and public benefit company exploring the business of biotech. For scientists, investors, and nerds of all stripes – or feathers.

Yinz respect the finch n@. 2026 Solt DB.
A white logo of LinkedIn.